Spero Therapeutics Announces Third Quarter 2021 Operating Results and Provides Business Update

NEXT STORY
Vor Reports Third Quarter 2021 Financial Results and Provides Company Update
PREV STORY
Sight Sciences Announces FDA Authorization for the PRECISION Trial, a Groundbreaking Three-Arm Randomized, Controlled IDE Trial of Canal Viscodilation in Combination with Cataract Surgery in Adults with Primary Open-Angle Glaucoma (POAG)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apricus Biosciences Provides Corporate Update and Second Quarter 2018 Financial Results

Company Enters Into Merger Agreement with Seelos Therapeutics, Inc. Apricus Shareholders Expected to Own ...

author_avatar
NASDAQ Market News

Notable Announces $40M Series B Round to Fuel Development of Its Drug Discovery Platform for Personalized Oncology

author_avatar
NASDAQ Market News

ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA

This announcement contains inside information 10 August 2016 14:35 ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA ...

author_avatar
NASDAQ Market News